KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) FCF Payout Ratio (2016 - 2025)

Historic FCF Payout Ratio for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to 0.61.

  • Pfizer's FCF Payout Ratio fell 6547.5% to 0.61 in Q3 2025 from the same period last year, while for Sep 2025 it was 3.16, marking a year-over-year increase of 3797.03%. This contributed to the annual value of 0.97 for FY2024, which is 4986.93% down from last year.
  • Pfizer's FCF Payout Ratio amounted to 0.61 in Q3 2025, which was down 6547.5% from 2.04 recorded in Q2 2025.
  • Pfizer's FCF Payout Ratio's 5-year high stood at 31.55 during Q2 2023, with a 5-year trough of 2.04 in Q2 2025.
  • In the last 5 years, Pfizer's FCF Payout Ratio had a median value of 0.46 in 2021 and averaged 2.55.
  • Examining YoY changes over the last 5 years, Pfizer's FCF Payout Ratio showed a top increase of 817344.51% in 2023 and a maximum decrease of 46097.67% in 2023.
  • Over the past 5 years, Pfizer's FCF Payout Ratio (Quarter) stood at 0.26 in 2021, then skyrocketed by 41.19% to 0.37 in 2022, then soared by 51.07% to 0.55 in 2023, then surged by 220.69% to 1.77 in 2024, then tumbled by 65.47% to 0.61 in 2025.
  • Its FCF Payout Ratio stands at 0.61 for Q3 2025, versus 2.04 for Q2 2025 and 1.38 for Q1 2025.